Maven Securities LTD P Lx Pharma Inc. Transaction History

Maven Securities LTD

  • $1.61 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$7.69 - $19.66 $1.54 Million - $3.94 Million
-200,377 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$12.22 - $21.28 $3.66 Million - $6.38 Million
-299,623 Reduced 59.92%
200,377 $3.87 Million
Q2 2021

Aug 16, 2021
BUY
$9.0 - $15.94 $4.5 Million - $7.97 Million
500,000 New
500,000 $6.52 Million

Others Institutions Holding PLXP

# of Institutions
4
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email